Monospecific antibodies reveal details of U2 snRNP structure and interaction between U1 and U2 snRNPs.

Por Mattaj, I W, Habets, W J, van Venrooij, W J
Publicado em 1986

Nitrogen control in Pseudomonas aeruginosa: mutants affected in the synthesis of glutamine synthetase, urease, and NADP-dependent glutamate dehydrogenase.

Por Janssen, D B, Habets, W J, Marugg, J T, Van Der Drift, C
Publicado em 1982

Molecular cloning of the cDNA for the human U2 snRNA-specific A' protein.

Por Sillekens, P T, Beijer, R P, Habets, W J, van Verooij, W J
Publicado em 1989

Human U1 snRNP-specific C protein: complete cDNA and protein sequence and identification of a multigene family in mammals.

Por Sillekens, P T, Beijer, R P, Habets, W J, van Venrooij, W J
Publicado em 1988

cDNA cloning of the human U1 snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific proteins.

Por Sillekens, P T, Habets, W J, Beijer, R P, van Venrooij, W J
Publicado em 1987

Zinc finger-like structure in U1-specific protein C is essential for specific binding to U1 snRNP.

Por Nelissen, R L, Heinrichs, V, Habets, W J, Simons, F, Lührmann, R, van Venrooij, W J
Publicado em 1991

Small nuclear RNA-associated proteins are immunologically related as revealed by mapping of autoimmune reactive B-cell epitopes.

Por Habets, W J, Sillekens, P T, Hoet, M H, McAllister, G, Lerner, M R, van Venrooij, W J
Publicado em 1989

Characterization of the SS-B (La) antigen in adenovirus-infected and uninfected HeLa cells.

Por Habets, W J, den Brok, J H, Boerbooms, A M, van de Putte, L B, van Venrooij, W J
Publicado em 1983

A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis.

Por Verheijen, R, Van den Hoogen, F, Beijer, R, Richter, A, Penner, E, Habets, W J, van Venrooij, W J
Publicado em 1990

Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.

Por Habets, W J, de Rooij, D J, Hoet, M H, van de Putte, L B, van Venrooij, W J
Publicado em 1985

Independent deposition of heterogeneous nuclear ribonucleoproteins and small nuclear ribonucleoprotein particles at sites of transcription.

Por Amero, S A, Raychaudhuri, G, Cass, C L, van Venrooij, W J, Habets, W J, Krainer, A R, Beyer, A L
Publicado em 1992

Scl-86, a marker antigen for diffuse scleroderma.

Por van Venrooij, W J, Stapel, S O, Houben, H, Habets, W J, Kallenberg, C G, Penner, E, van de Putte, L B
Publicado em 1985

Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.

Por Habets, W J, Hoet, M H, Sillekens, P T, De Rooij, D J, Van de Putte, L B, Van Venrooij, W J
Publicado em 1989

Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.

Por de Rooij, D J, Habets, W J, van de Putte, L B, Hoet, M H, Verbeek, A L, van Venrooij, W J
Publicado em 1990

Analysis of a cDNA clone expressing a human autoimmune antigen: full-length sequence of the U2 small nuclear RNA-associated B" antigen.

Por Habets, W J, Sillekens, P T, Hoet, M H, Schalken, J A, Roebroek, A J, Leunissen, J A, van de Ven, W J, van Venrooij, W J
Publicado em 1987

Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.

Por Habets, W J, de Rooij, D J, Salden, M H, Verhagen, A P, van Eekelen, C A, van de Putte, L B, van Venrooij, W J
Publicado em 1983